Articles, Blog

Biomolecular medicine on cancer

By Dr. Jorge Vargas

Doctor of 

Actually, cancer is the second cause of deaths in the world, one of six deaths in the world secondary to cancer. The word cancer refers to a group complex of illness, that have the characteristics of generating a fast multiplication in the different cells of the body and can affect other systems or close organs and when that occurs it makes reference to metastasis. Metastasis it’s the principal cause of death in cancers. 

The principal objective of biomolecular medicine is to prevent and delay the occurrence of cancer as well as improve the quality of life during the disease. It is demonstrated that the early detection and early treatment at stages 1 and 2 of cancer are shown to have a better evolution and pronostic, while stage 3 and 4 improve quality of life only as a palliative treatment.

Actually the 5 most common zone cancer in Guatemala are:


  • Stomach
  • Liver
  • Lungs
  • prostate
  • Leukemia


  • Stomach
  • Liver 
  • Uterine cervix
  • Uterine body
  • Leukemia


The cancer originates by transformation of normal cells into tumoral cells that occur in different stages, consists of progression precancerous lesion to malignant tumor. These changes are secondary to a genetic factor and physical, chemistry and biological factors.  

Some cancers may not form tumors, and not all the tumors are malignant. There are tumors that grow at a slow pace, which are not disseminated or infiltrated by the neighbor’s tissues and are considered benign.

Risk factors

Cancer develops as part of multifactorial causes, it’s conditioned by different several risks. Tobacco, alcohol, poor diet, physical inactivity. Some chronic infections are associated like helicobacter pylori, papillomavirus, hepatitis virus and Epstein barr virus.


The early diagnostic remains through interrogation and physical examination, always it’s going to be necessary laboratory and imaging tests and to confirm the diagnosis it’s necessary a histologic test.


Currently pharmalat corporation through biomolecular medicine developed a new alternative in the treatment of cancer.

Which aims to reduce physical deterioration and secondary symptoms as well as prevent their progression.

Oconex, focused on treatment as an adjuvant in cancer, helps prevent physical deterioration as well as reduce adverse effects caused by conventional treatments. Oconex acts in the different cellular mechanisms of carcinogenesis, mainly indicated in stages 1 and 2 of cancer, however, in stages 3 and 4 reduces symptoms such as nausea, vomiting, pain, aids the mood, among others so it improves quality of life.